Clinical Trial Update: Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 feasibility study in adults with mild to moderate Alzheimer's disease completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• T3D Therapeutics investigational agent

Snippet

Sponsor: T3D Therapeutics, Inc. | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-30